West Island Brands Inc.

CNSX:WIB Stock Report

Market Cap: CA$2.0m

West Island Brands Valuation

Is WIB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WIB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate WIB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate WIB's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for WIB?

Key metric: As WIB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for WIB. This is calculated by dividing WIB's market cap by their current revenue.
What is WIB's PS Ratio?
PS Ratio0.4x
SalesCA$4.66m
Market CapCA$1.96m

Price to Sales Ratio vs Peers

How does WIB's PS Ratio compare to its peers?

The above table shows the PS ratio for WIB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
LOBE Lobe Sciences
3.5xn/aCA$2.6m
CHOO Choom Holdings
0.1xn/aCA$2.3m
HERB Herbal Dispatch
0.6xn/aCA$4.9m
SUGR.H SugarBud Craft Growers
0.3xn/aCA$718.6k
WIB West Island Brands
0.4xn/aCA$2.0m

Price-To-Sales vs Peers: WIB is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (2.5x).

Price to Sales Ratio vs Industry

How does WIB's PS Ratio compare vs other companies in the CA Pharmaceuticals Industry?

31 CompaniesPrice / SalesEstimated GrowthMarket Cap
AYR.A Ayr Wellness
0.2x2.6%US$89.06m
IAN iAnthus Capital Holdings
0.3xn/aUS$47.62m
DB Decibel Cannabis
0.3x11.8%US$20.42m
ACRG.A.U Acreage Holdings
0.1xn/aUS$26.82m
WIB 0.4xIndustry Avg. 0.8xNo. of Companies31PS01.22.43.64.86+
31 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: WIB is good value based on its Price-To-Sales Ratio (0.4x) compared to the Canadian Pharmaceuticals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is WIB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WIB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate WIB's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Verano Holdings

CA$845.9m

Operates as a vertically integrated multi-state cannabis operator in the United States.

VRNO

CA$2.39

7D

14.9%

1Y

-59.1%

Fennec Pharmaceuticals

US$109.5m

Operates as a biopharmaceutical company in the United States.

FRX

US$5.68

7D

-3.6%

1Y

-49.7%

Medexus Pharmaceuticals

CA$55.2m

Operates as a pharmaceutical company in Canada and the United States.

MDP

CA$2.24

7D

14.3%

1Y

47.4%